CD8A and Merkel cell skin cancer: Importantly, analysis of 16 MCPyV CD8+ TIL epitopes and their restricting HLA alleles covered almost 100% of patients with MCPyV+ MCC, indicating that active vaccination targeting these T-antigen-specific T cells may be a suitable therapy for MCC.